Showing 1 - 20 results of 146 for search 'columbia data analysis, llc*', query time: 0.16s Refine Results
  1. 1
    Treatment Patterns for Patients on Overactive Bladder Therapy: A Retrospective Statistical Analysis Using Canadian Claims Data

    Treatment Patterns for Patients on Overactive Bladder Therapy: A Retrospective Statistical Analysis Using Canadian Claims Data by Adrian Wagg, Demitri Diles, Todd Berner

    Published 2016-10-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Progression of Heart Failure in People with Type 2 Diabetes in Germany: An Analysis Using German Health Insurance Claims Data

    Progression of Heart Failure in People with Type 2 Diabetes in Germany: An Analysis Using German Health Insurance Claims Data by Keni Cheng-Siang Lee, Tobias Wagner, Adee Kennedy, Michael Wilke

    Published 2024-08-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    A Characterisation and Profiling of District Health Indicators in Zimbabwe: An Application of Principal Component Analysis in a Data Limited Setting

    A Characterisation and Profiling of District Health Indicators in Zimbabwe: An Application of Principal Component Analysis in a Data Limited Setting by Shepherd Shamu, Simbarashe Rusakaniko, Charles Hongoro

    Published 2015-12-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Re-challenge of Platinum-based Chemotherapy for Platinum-refractory Patients with Recurrent or Metastatic Head and Neck Cancer: Claims Data Analysis in Japan

    Re-challenge of Platinum-based Chemotherapy for Platinum-refractory Patients with Recurrent or Metastatic Head and Neck Cancer: Claims Data Analysis in Japan by Makoto Tahara, Issei Doi, Tatsunori Murata, Sari Mishina, Shinji Takai, Hirokazu Kaneko

    Published 2020-05-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    The Impact of Baseline Risk Factors on the Incidence of Febrile Neutropenia in Breast Cancer Patients Receiving Chemotherapy with Pegfilgrastim Prophylaxis: A Real-World Data Analysis

    The Impact of Baseline Risk Factors on the Incidence of Febrile Neutropenia in Breast Cancer Patients Receiving Chemotherapy with Pegfilgrastim Prophylaxis: A Real-World Data Analy... by Edward Li, Bridgette Kanz Schroader, David Campbell, Kim Campbell, Weijia Wang

    Published 2021-06-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Applied Comparison of Meta-analysis Techniques

    Applied Comparison of Meta-analysis Techniques by Li Wang, Colin Lewis-Beck, Elyse Fritschel, Erdem Baser, Onur Baser

    Published 2013-02-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Use of Healthcare Claims Data to Generate Real-World Evidence on Patients With Drug-Resistant Epilepsy: Practical Considerations for Research

    Use of Healthcare Claims Data to Generate Real-World Evidence on Patients With Drug-Resistant Epilepsy: Practical Considerations for Research by Nicole Stamas, Tom Vincent, Kathryn Evans, Qian Li, Vanessa Danielson, Reginald Lassagne, Ariel Berger

    Published 2024-02-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    THE ETHICAL STARTUP?

    THE ETHICAL STARTUP? by Alexis Walker

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Healthcare Costs and Resource Use Associated With Cervical Intraepithelial Neoplasia and Cervical Conization: A Retrospective Study of German Statutory Health Insurance Claims Data

    Healthcare Costs and Resource Use Associated With Cervical Intraepithelial Neoplasia and Cervical Conization: A Retrospective Study of German Statutory Health Insurance Claims Data by Anna-Janina Stephan, Miriam Reuschenbach, Kunal Saxena, Vimalanand S. Prabhu, Christian Jacob, Kim M. Schneider, Wolfgang Greiner, Regine Wölle, Monika Hampl

    Published 2022-05-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Health-Related Quality-of-Life Utility Values in Adults With Late-Onset Pompe Disease: Analyses of EQ-5D Data From the PROPEL Clinical Trial

    Health-Related Quality-of-Life Utility Values in Adults With Late-Onset Pompe Disease: Analyses of EQ-5D Data From the PROPEL Clinical Trial by Alison Griffiths, Simon Shohet, Neil Johnson, Alasdair MacCulloch

    Published 2024-09-01
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Treatment Patterns of Follicular Lymphoma in the United States: A Claims Analysis

    Treatment Patterns of Follicular Lymphoma in the United States: A Claims Analysis by Scott F. Huntington, Sreevalsa Appukkuttan, Wenyi Wang, Yuxian Du, Sari Hopson, Svetlana Babajanyan

    Published 2022-10-01
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    Cost-Effectiveness Analysis of a Heart Failure Management System in the United States

    Cost-Effectiveness Analysis of a Heart Failure Management System in the United States by Antonia Bosworth Smith, Ubong Silas, Alex Veloz, Peter Mallow, Barbara Pisani, Diana Bonderman, Rhodri Saunders

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    Cost-Effectiveness Analysis of Transanal Irrigation for Managing Neurogenic Bowel Dysfunction in Japan

    Cost-Effectiveness Analysis of Transanal Irrigation for Managing Neurogenic Bowel Dysfunction in Japan by Atsushi Sengoku, Shinichi Noto, Masashi Nomi, Anton Emmanuel, Tatsunori Murata, Toshiki Mimura

    Published 2018-02-01
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    Health Economic Analysis of Two-Layer Bandage System for Treatment of Chronic Venous Insufficiency

    Health Economic Analysis of Two-Layer Bandage System for Treatment of Chronic Venous Insufficiency by Peter J. Mallow

    Published 2023-08-01
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    Projecting the Potential Budget Impact Analysis of Paliperidone Palmitate in Egyptian Adult Patients with Schizophrenia

    Projecting the Potential Budget Impact Analysis of Paliperidone Palmitate in Egyptian Adult Patients with Schizophrenia by Gihan Elsisi, Mohamed Ezzat, Mohamed Ramadan

    Published 2023-08-01
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    Cost Analysis and Clinical Outcomes of Ambulatory Care Monitoring in Medicare Patients: Describing the Diagnostic Odyssey

    Cost Analysis and Clinical Outcomes of Ambulatory Care Monitoring in Medicare Patients: Describing the Diagnostic Odyssey by Renée JG Arnold, Andrew Layton

    Published 2015-02-01
    Get full text
    Article
    Save to List
    Saved in:
  17. 17
    Cost-effectiveness Analysis of Ribociclib plus Letrozole versus Palbociclib plus Letrozole in the United Kingdom

    Cost-effectiveness Analysis of Ribociclib plus Letrozole versus Palbociclib plus Letrozole in the United Kingdom by Gaurav Suri, David Chandiwana, Adam Lee, Rohit Mistry

    Published 2019-04-01
    Get full text
    Article
    Save to List
    Saved in:
  18. 18
    Network Meta-Analysis of Once Weekly Selinexor-Bortezomib-Dexamethasone in Previously Treated Multiple Myeloma

    Network Meta-Analysis of Once Weekly Selinexor-Bortezomib-Dexamethasone in Previously Treated Multiple Myeloma by Michael Dolph, Gabriel Tremblay, Adrienne M Gilligan, Hoyee Leong

    Published 2021-08-01
    Get full text
    Article
    Save to List
    Saved in:
  19. 19
    A Cost-effectiveness Analysis of Brentuximab Vedotin in Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma

    A Cost-effectiveness Analysis of Brentuximab Vedotin in Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma by Margaret Hux, Denise Zou, Esprit Ma, Peter Sajosi, Andreas Engstrom, Ross Selby, Eugene Benson, Andrew Briggs, Vijayveer Bonthapally

    Published 2016-10-01
    Get full text
    Article
    Save to List
    Saved in:
  20. 20
    Rapid Point-of-Care Influenza Testing for Patients in German Emergency Rooms – A Cost-Benefit Analysis

    Rapid Point-of-Care Influenza Testing for Patients in German Emergency Rooms – A Cost-Benefit Analysis by Roland Diel, Albert Nienhaus

    Published 2019-12-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: